At a glance
| Abbreviation | EBOV |
|---|---|
| ICTV species | Orthoebolavirus zairense |
| Family | Filoviridae |
| Baltimore class | V — (−)ssRNA |
| Human infection | Human infection recorded; pattern not classified |
Also called: Ebola; Orthoebolavirus zairense
Riboviria › Negarnaviricota › Monjiviricetes › Mononegavirales › Filoviridae › Orthoebolavirus
What it is
Taxonomy copied from ICTV MSL41.v1 / VMR_MSL41.v1.20260729.xlsx. These ranks are not hand-edited; a correction means re-running the fetch against a newer release.
| Realm | Riboviria |
|---|---|
| Kingdom | Orthornavirae |
| Phylum | Negarnaviricota |
| Class | Monjiviricetes |
| Order | Mononegavirales |
| Family | Filoviridae |
| Genus | Orthoebolavirus |
| ICTV identifier | ICTV19950287 |
| NCBI taxon | 3052462 |
| Exemplar isolate | AF086833 |
Host evidence
- human: 3,081 GenBank records
Counts of nucleotide records annotated with that host. Evidence of provenance, not a statement of host range.
Where it occurs
Not searched yet. No country-level occurrence data has been curated for this virus. The WHO reported-case data on this site covers a limited set of diseases; a virus outside it gets no map rather than an empty one.
What it does
Not searched yet. Burden, severity and transmissibility figures have not been curated for this virus yet. When they are, each will carry the exact sentence from its source.
Vaccines
| Name | Developer | Platform | Use | Stage | Jurisdictions | Trials | Source |
|---|---|---|---|---|---|---|---|
| Ebola Zaire Vaccine, Live | See FDA listing | Not searched yet | Outbreak response | Approved | US: approved | — | candidateId fda-ebola-zaire-vaccine-live (targetDisease 'Ebola'); stag |
In development
| Name | Developer | Platform | Use | Stage | Jurisdictions | Trials | Source |
|---|---|---|---|---|---|---|---|
| Ad26.ZEBOV | Janssen Vaccines & Prevention B.V. | Not searched yet | Outbreak response | Discontinued | Not searched yet | NCT02661464 | candidateId ctgov-ad26-zebov-janssen-vaccines-prevention-b-v (targetDi |
Antivirals
Not searched yet. No US-approved antiviral for this virus was found in the openFDA drug label endpoint. Only US labels were searched, and only drugs the FDA classes as antivirals.
Antibodies and immune globulins
| Name | Mechanism | Use | Stage | Jurisdictions | Trials | Source |
|---|---|---|---|---|---|---|
| AnsuvimabEbanga | Not searched yet | Treatment | Approved | US: approved | — | quote1 INDICATIONS AND USAGE EBANGA is indicated for the treatment of infection caused by Orthoebolavirus zairense (formerly Zaire ebolavirus) in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Orthoebolavirus zairense infection [see Dosage and Administration (2.2) and Clinical Studies (14) ]. Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]; SPL id 58f2d4af-2a78-c5f5-e063-6294a90a36bb · verified 2026-10-30 |
Approval status is not a treatment recommendation. Dosing and eligibility are on the label and in national guidelines. This page does not give medical advice and does not render dosing. A development stage is not a measure of how well something works.
Related on this site
- Vaccine pipeline — candidates listed under “Ebola”
- Other Filoviridae viruses